Products
Tropis
Stratis
Applications
Nucleic Acid Vaccines
COVID-19
Polio
Influenza
Resources
Press Coverage
News Releases
Publications
FAQs
Our Blogs
Events
About
About Pharmajet
Partnerships
Needle-free Technology
Contact
Publications
All Categories
Clinical Studies (6)
Pre-Clinical Studies (8)
All Tags
Adjuvants (1)
ANDV (3)
Arboviruses (10)
Atherosclerosis (1)
Cancer (3)
Clinical (2)
COVID-19 (9)
Cow (3)
Dengue (5)
DNA (24)
DOBV (1)
Equine Influenza (1)
Hamster (2)
Hantaviruses (5)
Hepatitis B (1)
HIV (1)
HNTV (1)
Horse (1)
HPV (1)
HTNV (1)
Improved Performance (14)
Inactivated (13)
Infectious Diseases (1)
Influenza (5)
Live Attenuated (7)
Lymphoma (1)
Mice (1)
MMR (3)
Mouse (2)
Nanoparticle (1)
Non-Human (1)
Non-Human Primate (10)
Other Applications (2)
Other Viruses (9)
Pentavalent (1)
Phase 1 (5)
Phase 1: Zika (1)
Phase 1/2 (2)
Phase 1/2: COVID-19 (1)
Phase 1b (1)
Phase 2 (2)
Phase 2/3 (1)
Phase 3 (1)
Phase 3/4 (1)
Phase 4 (3)
Pig (5)
Polio (11)
Pox (3)
Protein Subunit (2)
PRRSV (1)
PUUV (2)
Rabbit (4)
Rabies (2)
Respiratory Viruses (12)
RNA (3)
SEOV (1)
SNV (2)
Stratis (27)
Tropis (33)
Tropis/Stratis (7)
VEEV (2)
Zika (6)
Reset
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
2022
Houser, KV
Tags:
Improved Performance
,
Influenza
,
Phase 1
,
Stratis
View
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
2021
Lassaunière, R
Tags:
COVID-19
,
DNA
,
Improved Performance
,
Mice
,
Non-Human Primate
,
Rabbit
,
Stratis
View
Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
2021
Alamri, SS
Tags:
COVID-19
,
DNA
,
Improved Performance
,
Mouse
,
Respiratory Viruses
,
Tropis
View
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
2021
Momin, T
Tags:
DNA
,
Improved Performance
,
Phase 1/2: COVID-19
,
Respiratory Viruses
,
Tropis
View
Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines
2021
Brocato, RL
Tags:
ANDV
,
DNA
,
DOBV
,
Hamster
,
Hantaviruses
,
HTNV
,
Improved Performance
,
PUUV
,
SEOV
,
SNV
View
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
2021
Yadav, P
Tags:
COVID-19
,
DNA
,
Improved Performance
,
Non-Human Primate
,
Respiratory Viruses
,
Tropis
View
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
2021
Brocato, RL
Tags:
COVID-19
,
DNA
,
Hamster
,
Improved Performance
,
Respiratory Viruses
,
Tropis
View
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
2020
Teixeira, L
Tags:
Cancer
,
DNA
,
Improved Performance
,
Phase 1
,
Tropis
View
Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
2019
Armbruster, N
Tags:
Improved Performance
,
Other Viruses
,
Phase 1
,
Rabies
,
RNA
,
Stratis
,
Tropis
,
Tropis/Stratis
View
A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection
2019
Bernelin-Cottet, C
Tags:
DNA
,
Improved Performance
,
Other Viruses
,
Pig
,
PRRSV
,
Tropis
View
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
2018
Gaudinski, MR
Tags:
Arboviruses
,
DNA
,
Improved Performance
,
Phase 1: Zika
,
Stratis
View
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
2017
Alberer, M
Tags:
Improved Performance
,
Other Viruses
,
Phase 1
,
Rabies
,
RNA
,
Stratis
,
Tropis
,
Tropis/Stratis
View
1
2
»
Menu